Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

8.73
Delayed Data
As of Dec 08
 +0.02 / +0.23%
Today’s Change
2.38
Today|||52-Week Range
8.81
+106.87%
Year-to-Date
No recent news for Array Biopharma Inc.

Today’s Trading

Previous close8.71
Today’s open8.68
Day’s range8.42 - 8.76
Volume3,402,238
Average volume (3 months)5,559,087
Market cap$1.5B
Dividend yield--
Data as of 4:00pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)-1,028.57%
Earnings growth (this year)-18.63%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+165.62%
P/E ratioNM
Price/Sales3.69
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...-3.35-8.42%
CLVSClovis Oncology Inc-1.07-2.79%
TBPHTheravance Biopharma...+1.23+4.22%
AXONAxovant Sciences Ltd+0.01+0.07%
Data as of 4:01pm ET, 12/08/2016

Financials

Next reporting dateFebruary 7, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$137.9M
Annual profit (last year)-$92.8M
Net profit margin-67.33%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts


Search for Jobs